Florida 2024 Regular Session

Florida House Bill H0065

Introduced
9/20/23  
Refer
10/5/23  
Introduced
9/20/23  
Refer
10/5/23  
Refer
10/5/23  
Failed
3/8/24  
Refer
10/5/23  

Caption

Anaphylaxis in Public Schools

Impact

The enactment of HB 0065 will significantly impact state laws concerning student health and safety, especially in public schools. By formalizing the approach to handling food allergies and other allergen-induced emergencies, the bill aims to reduce risks associated with anaphylaxis among students. It requires that at least 50 percent of school personnel involved in before-school and after-school programs complete necessary training within a three-month timeframe after employment, ensuring that educators and caregivers are adequately prepared to respond to potential allergic reactions, which could save lives and minimize health risks for affected students.

Summary

House Bill 0065 is a legislative initiative aimed at enhancing the management of anaphylaxis in public schools across Florida. This bill mandates that each district school board adopt a comprehensive anaphylaxis policy to be implemented in every school within the district. The new policy must be published on both the Department of Education's website and the respective school district's website, ensuring transparency and accessibility of vital information regarding the management of allergic reactions. Furthermore, the policy will obligate school boards to provide detailed guidelines and emergency protocols for responding to anaphylactic incidents, ensuring that educational institutions are equipped to handle such emergencies effectively.

Contention

While the bill has been welcomed as a necessary measure to improve safety in schools, it also raises questions regarding the practicalities of training and policy implementation. Some stakeholders may express concerns about the resource allocation needed for training and the potential for varying interpretations of the required procedures among different school districts. Balancing the responsibilities imposed by the bill with the operational capabilities of schools could be contested among lawmakers and educational administrators, particularly regarding funding and the prioritization of health policies in school systems.

Companion Bills

FL S0052

Same As Anaphylaxis in Public Schools

Previously Filed As

FL H1197

Anaphylaxis in Public Schools

FL HB1197

Anaphylaxis in Public Schools:

FL S1514

Anaphylaxis in Public and Charter Schools

FL SB5240

Concerning anaphylaxis medications in schools.

FL H0963

Administrative Efficiency in Public Schools

FL H1009

Religious and Patriotic Expression in the Public School System

FL HB63

Relative to the use of nasal spray to treat anaphylaxis.

FL SB1887

Schools; modifying frequency of training on food allergies, anaphylaxis, epinephrine administration, and concussions. Effective date. Emergency.

FL H1253

Athletics in Public K-12 Schools

FL H0859

Exceptional Students and Video Cameras in Public Schools

Similar Bills

AR HB1817

To Establish Elijah's Law In Arkansas; And To Require The Department Of Health And The Department Of Education To Establish A Statewide Anaphylaxis Policy For Childcare Facilities.

NJ S759

Requires under certain circumstances development by certified school nurse of individualized health care plan and individualized emergency health care plan for student with life-threatening allergies or anaphylaxis.

WA SB5240

Concerning anaphylaxis medications in schools.

MS HB339

School districts; require all schools to have epinephrine auto-injectors in every building and cafeteria.

NJ S3624

Concerns food allergy safety, emergency preparedness, and anaphylaxis response in child care settings.

NJ A4789

Concerns food allergy safety, emergency preparedness, and anaphylaxis response in child care settings.

MS SB2197

Epinephrine auto-injectors; allow certain entities to stock and provide or administer during anaphylactic emergencies.

NE LB457

Require anaphylaxis policies for school districts and licensed child care facilities and provide a limit on the amount an insured is required to pay by an insurance policy or benefit plan for epinephrine injectors